Related Experiment Videos
DNA damage signalling and NF-kappaB: implications for survival and death in mammalian cells
1Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QP, UK. mpb28@cam.ac.uk
Abstract:
Nuclear factor kappaB (NF-kappaB), p53 and signal transducer and activator of transcription (STAT) proteins are transcription factors that are known to regulate cell fate in response to apoptotic stimuli. They may, therefore, represent components of drug responses that determine drug efficacy. This review will describe data illustrating some recent progress in our understanding of the mechanism of NF-kappaB activation after treatment of cells with DNA-damaging anti-cancer drugs. Furthermore, it will discuss how this and other transcriptional events, including STAT transcription factor activation, may effect the promotion or attenuation of apoptosis in target cells. In this regard, certain STAT family members may lie downstream of signalling pathways that are activated after DNA damage. Finally, it will be discussed how proteins normally linked with DNA damage signalling such as p53 may be regulated in response to physiological signals, revealing their role in developmental checkpoints such as differentiation commitment.
Insights
This review explores how transcription factors like Nuclear Factor kappaB (NF-kappaB) and Signal Transducer and Activator of Transcription (STAT) proteins influence anti-cancer drug efficacy by regulating cell death pathways. Understanding these mechanisms is key to improving cancer treatments.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Transcription factors, including Nuclear Factor kappaB (NF-kappaB), p53, and Signal Transducer and Activator of Transcription (STAT) proteins, are critical regulators of cell fate.
- These proteins play a significant role in cellular responses to apoptotic stimuli and may influence the efficacy of anti-cancer drugs.
Purpose of the Study:
- To review recent advancements in understanding NF-kappaB activation mechanisms following DNA-damaging anti-cancer drug treatment.
- To discuss the role of NF-kappaB, STATs, and p53 in modulating apoptosis and influencing drug response in cancer cells.
Main Methods:
- Literature review of studies investigating NF-kappaB activation pathways.
- Analysis of research on STAT transcription factor activation downstream of DNA damage signaling.
- Examination of p53 regulation in response to physiological signals and its role in differentiation.
Main Results:
- NF-kappaB activation is a key event following treatment with DNA-damaging anti-cancer drugs.
- STAT transcription factors may be activated downstream of DNA damage and can either promote or inhibit apoptosis.
- p53 proteins are involved in DNA damage signaling and are regulated by physiological signals, impacting developmental checkpoints.
Conclusions:
- Understanding the interplay between transcription factors (NF-kappaB, STATs, p53) and DNA damage signaling is crucial for elucidating anti-cancer drug mechanisms and efficacy.
- Targeting these transcription factors or their pathways may offer novel therapeutic strategies for cancer treatment.
- The regulation of these factors in response to physiological signals highlights their broader roles in cell fate determination and development.